Chemoinformaics analysis of RHAMNETIN-3-RHAMNOSIDE
| Molecular Weight | 462.407 | nRot | 4 |
| Heavy Atom Molecular Weight | 440.231 | nRig | 24 |
| Exact Molecular Weight | 462.116 | nRing | 4 |
| Solubility: LogS | -4.051 | nHRing | 2 |
| Solubility: LogP | 1.476 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 2 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 17 |
| nHA | 11 | APOL | 60.2314 |
| nHD | 6 | BPOL | 29.8826 |
| QED | 0.302 |
| Synth | 3.955 |
| Natural Product Likeliness | 1.965 |
| NR-PPAR-gamma | 0.96 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.013 |
| Pgp-sub | 0.87 |
| HIA | 0.515 |
| CACO-2 | -5.995 |
| MDCK | 0.0000111 |
| BBB | 0.013 |
| PPB | 0.874194 |
| VDSS | 0.872 |
| FU | 0.120467 |
| CYP1A2-inh | 0.083 |
| CYP1A2-sub | 0.216 |
| CYP2c19-inh | 0.021 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0.051 |
| CYP2c9-sub | 0.666 |
| CYP2d6-inh | 0.144 |
| CYP2d6-sub | 0.243 |
| CYP3a4-inh | 0.062 |
| CYP3a4-sub | 0.035 |
| CL | 6.234 |
| T12 | 0.719 |
| hERG | 0.009 |
| Ames | 0.808 |
| ROA | 0.068 |
| SkinSen | 0.093 |
| Carcinogencity | 0.098 |
| EI | 0.082 |
| Respiratory | 0.05 |
| NR-Aromatase | 0.911 |
| Antiviral | Yes |
| Prediction | 0.89951 |